Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial

Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software update without changing the study information shown.
    Difference
    0.0%
    Check dated 2026-04-24T06:18:46.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:47:03.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a related topic entry for hereditary factor VIII deficiency disease and the Genetic and Rare Diseases Information Center resources.
    Difference
    0.1%
    Check dated 2026-04-02T15:39:53.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Removed the Hemophilia A reference and the Genetic and Rare Diseases Information Center resource from the page.
    Difference
    0.1%
    Check dated 2026-03-26T11:49:26.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Site template revision updated from version v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T06:32:56.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Site revision log updated: added Revision v3.4.3 and removed Revision v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T02:22:38.000Z thumbnail image

Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.